Further analysis verified that in VHL-deficient ccRCC patients, the expression of CASP9 was substantially reduced in the SIRT4 low-expression subset compared to the SIRT4 high-expression subset. This evidence concerns the gene CASP9 and nonpapillary renal cell carcinoma.